General Conduct of Development. The parties shall conduct their respective obligations under the Ultrio Development Program in compliance in all material respects with all requirements of applicable laws and regulations and all applicable good laboratory, clinical and manufacturing practices. In addition, the parties each shall proceed diligently with their respective obligations under the Ultrio Development Program and shall use their respective Commercially Reasonable Efforts to achieve the objectives of the Ultrio Development Program efficiently and expeditiously. The parties each shall allocate such personnel, equipment, facilities and other resources to the Ultrio Development Program to carry out their respective obligations and to accomplish the objectives thereof, all as is more particularly described in the Ultrio Development Program, as amended from time to time during the term of this Ultrio Addendum (in accordance with the provisions of Section 3). Each party shall have the right to consult with the other party regarding the Ultrio Development Program and the obligation to reasonably consider the other party's advice.
Appears in 2 contracts
Sources: Future Blood Screening Assay—ultrio Addendum (Chiron Corp), Addendum (Gen Probe Inc)